66.5JPY
89.33 BJPY
820.21 BJPY
1.22 B
About TERUMO CORP
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Employees (FY)
30.21 K
Founded
1921
ISIN
JP3546800008
FIGI
BBG000BK09M8
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4543 is 2641.00 JPY — it has increased by 2.07% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TERUMO CORP stocks are traded under the ticker 4543.
TERUMO CORP is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for TERUMO CORP has a max estimate of 3550.00 JPY and a min estimate of 2450.00 JPY.
4543 earnings for the last quarter are 18.50 JPY whereas the estimation was 15.82 JPY which accounts for 16.88% surprise. Estimated earnings for the next quarter are 19.77 JPY. See more details about TERUMO CORP earnings.
TERUMO CORP revenue for the last quarter amounts to 228.62 B JPY despite the estimated figure of 219.11 B JPY. In the next quarter revenue is expected to reach 227.48 B JPY.
Yes, you can track TERUMO CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4543 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TERUMO CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 30.21 K employees. See our rating of the largest employees — is TERUMO CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TERUMO CORP EBITDA is 200.77 B JPY, and current EBITDA margin is 22.87%. See more stats in TERUMO CORP financial statements.